Search Results - "이계영"
-
1
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study
Published in Cancer research and treatment (01-10-2023)“…To report the final analysis of time-on-treatment (TOT) and overall survival (OS) in patients with advanced-stage EGFR+ non-small-cell lung cancer (NSCLC) who…”
Get full text
Journal Article -
2
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
Published in Cancer research and treatment (01-01-2023)“…Although osimertinib is the standard-of-care treatment of epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer,…”
Get full text
Journal Article -
3
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
Published in Journal of pathology and translational medicine (01-11-2020)“…Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations…”
Get full text
Journal Article -
4
Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
Published in Journal of Korean medical science (01-08-2016)“…EGFR and KRAS mutations are two of the most common mutations that are present in lung cancer. Screening and detecting these mutations are of issue these days,…”
Get full text
Journal Article -
5
The Relationship between Neural Foraminal Stenosis and Imaging Features of Lumbar Spine MRI in Patients Older Than 60 Years with Lumbar Radiculopathy
Published in Journal of the Korean Society of Radiology (01-07-2021)“…Purpose To investigate the MRI features associated with neural foraminal stenosis (NFS) in patients older than 60 years with lumbar (L) radiculopathy…”
Get full text
Journal Article -
6
Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Published in Cancer research and treatment (01-06-2013)“…Since the first description of non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation as a distinct clinical…”
Get full text
Journal Article -
7
Bilateral Ovarian Metastases from ALK Rearranged Non-Small Cell Lung Cancer
Published in Tuberculosis and respiratory diseases (01-12-2014)“…Anaplastic lymphoma kinase (ALK) rearrangement, is a kind of driver mutation, accounts for 3%-5% of non-small cell lung cancer (NSCLC). NSCLC patients…”
Get full text
Journal Article -
8
Bilateral Internal Auditory Canal Metastasis of Non-small Cell Lung Cancer
Published in Cancer research and treatment (01-01-2015)“…We report on a patient with brain metastasis involving bilateral internal auditory canal from non-small cell lung cancer (NSCLC). A 49-year-old woman who had…”
Get full text
Journal Article -
9
A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
Published in Tuberculosis and respiratory diseases (01-10-2015)“…Cryptogenic organizing pneumonia (COP) is an inflammatory lung disease involving the distal bronchioles, respiratory bronchioles, bronchiolar ducts, and…”
Get full text
Journal Article -
10
Guideline of the Korean Academy of Medical Sciences for assessing respiratory impairment
Published in Journal of Korean medical science (01-05-2009)“…The presently used impairment rating guidelines in Korea do not accurately reflect the injury in various lung diseases. Therefore, they need to be made more…”
Get full text
Journal Article -
11
요추신경근병증이 있는 60세 이상의 환자에서 신경공 협착과 자기공명영상 평가를 통한 인자와의 상관관계
Published in Taehan Yŏngsang Ŭihakhoe chi (2021)“…Purpose To investigate the MRI features associated with neural foraminal stenosis (NFS) in patients older than 60 years with lumbar (L) radiculopathy…”
Get full text
Journal Article -
12
A Case of Congenital Cystic Adenomatoid Malformation Infected with Mycobacterium avium-intracellulare Complex
Published in Tuberculosis and respiratory diseases (01-01-2013)“…We present a case of congenital cystic adenomatoid malformation (CCAM) in a 25-year-old male who was presented with chronic cough. Chest radiography revealed…”
Get full text
Journal Article -
13
Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study (SELINE)
Published in Tuberculosis and respiratory diseases (01-12-2012)“…This study was designed to analyze the efficacy of gefitinib as a second-line therapy, according to the clinical characteristics in Korean patients with…”
Get full text
Journal Article -
14
Octanethiol coating of nano-sized copper powders using the vapor self-assembled monolayer method
Published in Metals and materials international (01-12-2009)“…Recent research has focused on preventing copper oxidation for direct wiring applications. In this study, a novel coating method was developed for nano-sized…”
Get full text
Journal Article -
15
A Case of Yellow Nail Syndrome: Misdiagnosis as Congestive Heart Failure
Published in Tuberculosis and respiratory diseases (01-07-2011)“…Yellow nail syndrome (YNS) is a rare disorder of unknown cause associated with yellow nails, lymphedema and respiratory manifestations. It was first described…”
Get full text
Journal Article -
16
폐암 검진 권고안
Published in Taehan Ŭisa Hyŏphoe chi (01-04-2015)“…Lung cancer is the leading cause of cancer death in many countries, including Korea. The majority of patients are inoperable at the time of diagnosis because…”
Get full text
Journal Article -
17
폐암세포주에서 NF-κB 활성 억제를 통한 Proteasome 억제제 MG132의 TRAIL-유도성 Apoptosis 감작 효과
Published in Tuberculosis and respiratory diseases (30-12-2008)“…연구배경: 정상세포는 보호되고 종양세포에 독성을 보인다고 알려진 TNF유전자족으로 새로이 확인된 TRAIL이 폐암세포에서 보이는 아포프토시스 효과를 확인하고, 아포프토시스로부터 세포를 보호하는 전사인자 NF-κB가 TRAIL에 의하여 활성화 되는 정도를 평가하여 MG132의…”
Get full text
Journal Article -
18
비소페포폐암에서 DR5 TRAIL 수용체와 p53에 관한 면역조직화학적 분석
Published in Tuberculosis and respiratory diseases (01-04-2008)“…연구배경: TRAIL 은 death 수용체(DR4, DR5)와 decoy 수용체(DcR1, DcR2)라는 독특한 수용체 시스템 덕분에 정상세포는 보호하고 종양선택적 살상능을 가진 유망한 항암제로 주목받고 있다. DR5 TRAIL 수용체는 wild-type p53 세포에서 DNA…”
Get full text
Journal Article -
19
폐암세포주에서 NFκ 활성 억제를 통한 Proteasome 억제제 MG132의 TRAIL-유도성 Apoptosis 감작 효과
Published in Tuberculosis and respiratory diseases (2008)“…Background: TRAIL (TNF-related apoptosis inducing ligand) is a newly identified member of the TNF gene family which appears to have tumor-selective…”
Get full text
Journal Article -
20
Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation
Published in Experimental & molecular medicine (01-12-2002)“…TNF-related apoptosis-inducing ligand (TRAIL/Apo- 2L), a newly identified member of the TNF family promotes apoptosis by binding to the transmem-brane…”
Get full text
Journal Article